ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Sep 29, 2014
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2014-09-25$0.31/sh+434,500$133,956→ 2,434,500 total(indirect: By IRA) - Purchase
Common Stock
2014-09-26$0.31/sh+265,500$82,385→ 2,700,000 total(indirect: By IRA)
Holdings
- 11,714,141
Common Stock